190 related articles for article (PubMed ID: 36197977)
21. Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutations.
Zhao Z; Cao K; Watanabe J; Philips CN; Zeidner JM; Ishi Y; Wang Q; Gold SR; Junkins K; Bartom ET; Yue F; Chandel NS; Hashizume R; Ben-Sahra I; Shilatifard A
J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37252797
[TBL] [Abstract][Full Text] [Related]
22. A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.
Lee J; Kim DH; Lee S; Yang QH; Lee DK; Lee SK; Roeder RG; Lee JW
Proc Natl Acad Sci U S A; 2009 May; 106(21):8513-8. PubMed ID: 19433796
[TBL] [Abstract][Full Text] [Related]
23. ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.
Micol JB; Pastore A; Inoue D; Duployez N; Kim E; Lee SC; Durham BH; Chung YR; Cho H; Zhang XJ; Yoshimi A; Krivtsov A; Koche R; Solary E; Sinha A; Preudhomme C; Abdel-Wahab O
Nat Commun; 2017 May; 8():15429. PubMed ID: 28516957
[TBL] [Abstract][Full Text] [Related]
24. Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors.
Lee S; Lee J; Lee SK; Lee JW
Mol Endocrinol; 2008 Jun; 22(6):1312-9. PubMed ID: 18372346
[TBL] [Abstract][Full Text] [Related]
25. Histone recognition and nuclear receptor co-activator functions of Drosophila cara mitad, a homolog of the N-terminal portion of mammalian MLL2 and MLL3.
Chauhan C; Zraly CB; Parilla M; Diaz MO; Dingwall AK
Development; 2012 Jun; 139(11):1997-2008. PubMed ID: 22569554
[TBL] [Abstract][Full Text] [Related]
26. H3.3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4 and impairs adipose tissue development.
Jang Y; Broun A; Wang C; Park YK; Zhuang L; Lee JE; Froimchuk E; Liu C; Ge K
Nucleic Acids Res; 2019 Jan; 47(2):607-620. PubMed ID: 30335158
[TBL] [Abstract][Full Text] [Related]
27. Additional sex combs-like 2 is required for polycomb repressive complex 2 binding at select targets.
Lai HL; Wang QT
PLoS One; 2013; 8(9):e73983. PubMed ID: 24040135
[TBL] [Abstract][Full Text] [Related]
28. PAQR3 modulates H3K4 trimethylation by spatial modulation of the regulatory subunits of COMPASS-like complexes in mammalian cells.
Liu C; Zhang Y; Hou Y; Shen L; Li Y; Guo W; Xu D; Liu G; Zhao Z; Man K; Pan Y; Wang Z; Chen Y
Biochem J; 2015 May; 467(3):415-24. PubMed ID: 25706881
[TBL] [Abstract][Full Text] [Related]
29. FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.
Jozwik KM; Chernukhin I; Serandour AA; Nagarajan S; Carroll JS
Cell Rep; 2016 Dec; 17(10):2715-2723. PubMed ID: 27926873
[TBL] [Abstract][Full Text] [Related]
30. A small UTX stabilization domain of Trr is conserved within mammalian MLL3-4/COMPASS and is sufficient to rescue loss of viability in null animals.
Rickels R; Wang L; Iwanaszko M; Ozark PA; Morgan MA; Piunti A; Khalatyan N; Soliman SHA; Rendleman EJ; Savas JN; Smith ER; Shilatifard A
Genes Dev; 2020 Nov; 34(21-22):1493-1502. PubMed ID: 33033055
[TBL] [Abstract][Full Text] [Related]
31. Circadian clock function does not require the histone methyltransferase MLL3.
Baxter M; Poolman T; Cunningham P; Hunter L; Voronkov M; Kitchen GB; Goosey L; Begley N; Kay D; Hespe A; Maidstone R; Loudon ASI; Ray DW
FASEB J; 2022 Jul; 36(7):e22356. PubMed ID: 35704036
[TBL] [Abstract][Full Text] [Related]
32. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
33. Structural basis of nucleosome recognition and modification by MLL methyltransferases.
Xue H; Yao T; Cao M; Zhu G; Li Y; Yuan G; Chen Y; Lei M; Huang J
Nature; 2019 Sep; 573(7774):445-449. PubMed ID: 31485071
[TBL] [Abstract][Full Text] [Related]
34. The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.
Abdel-Wahab O; Dey A
Leukemia; 2013 Jan; 27(1):10-5. PubMed ID: 23147254
[TBL] [Abstract][Full Text] [Related]
35. Distinct kinetic mechanisms of H3K4 methylation catalyzed by MLL3 and MLL4 core complexes.
Zheng Y; Huang Y; Mencius J; Li Y; Zhao L; Luo W; Chen Y; Quan S
J Biol Chem; 2021; 296():100635. PubMed ID: 33823156
[TBL] [Abstract][Full Text] [Related]
36. Regulation of H3K4 trimethylation via Cps40 (Spp1) of COMPASS is monoubiquitination independent: implication for a Phe/Tyr switch by the catalytic domain of Set1.
Takahashi YH; Lee JS; Swanson SK; Saraf A; Florens L; Washburn MP; Trievel RC; Shilatifard A
Mol Cell Biol; 2009 Jul; 29(13):3478-86. PubMed ID: 19398585
[TBL] [Abstract][Full Text] [Related]
37. Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation.
Douillet D; Sze CC; Ryan C; Piunti A; Shah AP; Ugarenko M; Marshall SA; Rendleman EJ; Zha D; Helmin KA; Zhao Z; Cao K; Morgan MA; Singer BD; Bartom ET; Smith ER; Shilatifard A
Nat Genet; 2020 Jun; 52(6):615-625. PubMed ID: 32393859
[TBL] [Abstract][Full Text] [Related]
38. Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.
Kato H; Asamitsu K; Sun W; Kitajima S; Yoshizawa-Sugata N; Okamoto T; Masai H; Poellinger L
Oncogene; 2020 Apr; 39(16):3322-3335. PubMed ID: 32071397
[TBL] [Abstract][Full Text] [Related]
39. Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.
Daou S; Barbour H; Ahmed O; Masclef L; Baril C; Sen Nkwe N; Tchelougou D; Uriarte M; Bonneil E; Ceccarelli D; Mashtalir N; Tanji M; Masson JY; Thibault P; Sicheri F; Yang H; Carbone M; Therrien M; Affar EB
Nat Commun; 2018 Oct; 9(1):4385. PubMed ID: 30349006
[TBL] [Abstract][Full Text] [Related]
40. Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS.
Lee JS; Shukla A; Schneider J; Swanson SK; Washburn MP; Florens L; Bhaumik SR; Shilatifard A
Cell; 2007 Dec; 131(6):1084-96. PubMed ID: 18083099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
